Jozef P.
- Country
- Czechia
- Department
- Klinické studie
Research Overview
- Evaluation of ISIS 678354 Sodium Salt in Patients with Severe Hypertriglyceridemia: A Randomized, Double-Blind, Placebo-Controlled Phase 3 Trial
- ZENITH: A Phase 3 Global, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Zilebesiran in Addition to Standard of Care in Reducing Major Adverse Cardiovascular Events in Adult Patients with Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk for Cardiovascular Disease
- An Open-Label Extension Study of Olezarsen (ISIS 678354) Administered Subcutaneously to Patients with Severe Hypertriglyceridemia (SHTG)
Data & Insights
Has run more than one trial at 96 of 544 partner sites.
Specializations
Metabolic Disorders
The investigator specializes in the treatment and research of severe hypertriglyceridemia, focusing on innovative therapeutic approaches for managing elevated triglyceride levels in patients.
- Lipid Metabolism Disorders
- Cardiovascular Risk Management
- Triglyceride-Related Conditions
Clinical expertise includes evaluation of novel therapeutic agents for the management of lipid disorders and their associated complications.
Therapeutic Focus
Dedicated to advancing treatment options for patients with metabolic disorders, particularly investigating new compounds for triglyceride reduction.
- Lipid-Lowering Therapies
- Novel Treatment Approaches
- Patient Response Assessment
Explores innovative therapeutic strategies for managing severe lipid disorders and their impact on patient health.
Clinical Interests
Focuses on the development of treatments for metabolic conditions affecting lipid metabolism and cardiovascular health.
- Metabolic Disease Management
- Cardiovascular Risk Prevention
- Treatment Efficacy Assessment
Examines the relationship between triglyceride levels and overall cardiovascular health outcomes.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.